Edmonds Duncan Registered Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Edmonds Duncan Registered Investment Advisors, LLC

$446 Million
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $183,319 - $230,492	-2,952 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $21,702 - $25,200	-300 Reduced 9.23%	2,952 $227,000
Q1 2020 Apr 07, 2020	BUY	$62.63 - $80.22 $1,377 - $1,764	22 Added 0.68%	3,252 $243,000
Q4 2019 Jan 30, 2020	SELL	$61.62 - $67.78 $6,162 - $6,778	-100 Reduced 3.0%	3,230 $210,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $25,004 - $27,600	-400 Reduced 10.72%	3,330 $211,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $12,506 - $14,010	-200 Reduced 5.09%	3,730 $242,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $115,026 - $150,100	-1,900 Reduced 32.59%	3,930 $246,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $38,491 - $42,616	-540 Reduced 8.48%	5,830 $450,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $6,488 - $7,568	100 Added 1.59%	6,370 $451,000
Q1 2018 May 23, 2018	BUY	$72.84 - $88.8 $20,686 - $25,219	284 Added 4.74%	6,270 $473,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $7,115 - $8,352	100 Added 1.7%	5,986 $428,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $36,055 - $42,735	-500 Reduced 7.83%	5,886 $430,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,386	6,386 $452,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmonds Duncan Registered Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edmonds Duncan Registered Investment Advisors, LLC with notifications on news.

Account